Tetra Technologies
TTI
6.12
-0.02
-0.33%
Tetra Technologies
US · TTI
#3307 by market cap
6.12
-0.02
-0.33%
Live - 5344 symbols - heartbeat 217s ago
· 2026-10-08 08:58
Pre-market
6.21
+1.47%
After-hours
6.17
+0.82%
Overnight
6.16
+0.65%
- Market cap
- 906.21M
- P/E (TTM)i
- 204.00
- P/Bi
- 2.22
- EPSi
- 0.02
- Div yieldi
- 0.00%
- 52W posi
- 7%
Reader sentiment
Are you bullish or bearish on TTI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.53, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +5.31% YoY
Margins
- Gross margin
- 24.72%
- Operating margin
- 8.78%
- Net margin
- 0.48%
Key ratios & quality
- Enterprise valuei
- 1.03B
- Altman Z-Scorei
- 2.53
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 560.10M | 561.24M | 377.72M | 388.27M | 553.21M | 626.26M | 599.11M | 630.93M |
| Gross profit | 103.28M | 11.81M | 67.54M | 59.24M | 121.11M | 153.65M | 139.85M | 155.95M |
| Selling & admin expenses | 92.90M | 96.47M | 76.70M | 75.05M | 91.94M | 96.59M | 89.97M | 100.56M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 10.38M | -84.66M | -9.15M | -15.81M | 22.53M | 44.94M | 49.88M | 55.39M |
| Pretax profit | -2.63M | -128.11M | -25.09M | -14.72M | 11.17M | 31.70M | 28.74M | 26.50M |
| Tax | 3.68M | 2.81M | 1.76M | 2.08M | 3.57M | 6.22M | -84.88M | 22.30M |
| Net profit | -84.24M | -160.50M | -98.93M | 103.60M | 7.80M | 25.76M | 108.28M | 3.00M |
| Basic EPS | -1 | -1 | 0 | 1 | 0 | 0 | 1 | 0 |
| Diluted EPS | -0.50 | -1.17 | -0.41 | 0.82 | 0.06 | 0.20 | 0.82 | 0.02 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 157.14M | 173.87M | 153.24M | 146.68M | 156.25M | 185.66M |
| Gross profit | 42.91M | 48.24M | 36.37M | 28.43M | 38.23M | 45.71M |
| Selling & admin expenses | 24.13M | 25.26M | 25.24M | 25.93M | 25.41M | 25.58M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 18.77M | 22.99M | 11.13M | 2.50M | 12.82M | 20.13M |
| Pretax profit | 5.09M | 19.44M | 8.11M | -6.13M | 11.59M | 15.85M |
| Tax | 1.04M | 8.13M | 3.95M | 9.17M | 3.27M | 5.62M |
| Net profit | 4.05M | 11.31M | 4.15M | -16.51M | 8.32M | 10.24M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.03 | 0.08 | 0.03 | -0.12 | 0.06 | 0.07 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 400.69M | 351.35M | 931.55M | 210.39M | 238.45M | 282.02M | 269.63M | 316.68M |
| Cash & ST investments | 40.04M | 15.33M | 67.25M | 31.55M | 13.59M | 52.49M | 36.99M | 72.63M |
| Inventory | 143.57M | 80.47M | 76.66M | 69.10M | 72.11M | 96.54M | 101.70M | 115.73M |
| Total assets | 1.39B | 1.27B | 1.13B | 398.27M | 434.37M | 478.96M | 605.20M | 675.76M |
| Total current liabilities | 200.35M | 188.72M | 798.08M | 97.14M | 124.27M | 125.96M | 123.35M | 156.46M |
| Short-term debt | -- | 9.14M | 8.80M | 8.11M | 7.80M | 9.10M | 8.86M | 11.33M |
| Long-term debt | 815.56M | 204.63M | 199.89M | 151.94M | 156.46M | 157.51M | 179.70M | 181.36M |
| Total liabilities | 1,072,778,000.00 | 1,109,096,000.00 | 1,061,777,000.00 | 299,703,000.00 | 327,969,000.00 | 331,627,000.00 | 351,888,000.00 | 393,274,000.00 |
| Total equity | 312.75M | 162.83M | 71.06M | 98.56M | 106.40M | 147.33M | 253.31M | 282.49M |
| Retained earnings | -217.95M | -362.52M | -413.67M | -310.33M | -302.49M | -276.71M | -168.43M | -165.42M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 291.05M | 311.63M | 313.88M | 316.68M | 297.17M | 410.97M |
| Cash & ST investments | 41.00M | 68.75M | 67.15M | 72.63M | 35.47M | 154.58M |
| Inventory | 106.49M | 108.54M | 105.86M | 115.73M | 119.97M | 117.06M |
| Total assets | 614.09M | 645.58M | 655.17M | 675.76M | 662.35M | 800.11M |
| Total current liabilities | 114.37M | 126.34M | 133.29M | 156.46M | 147.11M | 167.28M |
| Short-term debt | 9.33M | 10.73M | 10.61M | 11.33M | 17.84M | 20.01M |
| Long-term debt | 180.10M | 180.50M | 180.92M | 181.36M | 175.88M | 175.19M |
| Total liabilities | 342,342,000.00 | 355,958,000.00 | 359,749,000.00 | 393,274,000.00 | 376,730,000.00 | 393,587,000.00 |
| Total equity | 271.74M | 289.62M | 295.43M | 282.49M | 285.62M | 406.53M |
| Retained earnings | -164.38M | -153.07M | -148.92M | -165.42M | -157.10M | -146.86M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 46.59M | 90.23M | 76.91M | 4.66M | 18.96M | 70.21M | 36.52M | 100.36M |
| Depreciation & amortization | 117.01M | 124.28M | 118.75M | 33.53M | 32.82M | 34.33M | 35.72M | 37.10M |
| Free cash flow | -95.35M | -18.04M | 47.53M | -15.88M | -21.10M | 32.05M | -24.16M | 19.54M |
| Dividends paid | -19.22M | -1.23M | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 251.00K | -- | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 40.10M | 17.77M | 83.89M | 31.55M | 13.59M | 52.49M | 37.21M | 72.68M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 3.94M | 48.33M | 16.37M | 31.73M | -11.86M | 34.39M |
| Depreciation & amortization | 9.15M | 9.19M | 9.49M | 9.27M | 9.18M | 9.60M |
| Free cash flow | -14.02M | 28.85M | 627.00K | 4.09M | -30.88M | 11.07M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 41.05M | 68.80M | 67.20M | 72.68M | 35.52M | 154.63M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -32.30 | -141.90 | -413.56 | 229.47 | 7.56 | 20.13 | 53.72 | 1.12 |
| ROA %i | -4.57 | -11.09 | -4.25 | 13.50 | 1.88 | 5.65 | 19.98 | 0.47 |
| ROIC %i | -1.08 | -9.63 | -6.31 | 43.69 | 6.30 | 13.61 | 31.08 | 3.42 |
| 5-year avg ROE %i | -39.20 | -60.24 | -134.69 | -75.20 | -70.15 | -59.66 | -20.54 | 62.40 |
| EBIT margin %i | 3.46 | -6.83 | -1.63 | 0.43 | 4.88 | 8.63 | 8.55 | 6.95 |
| FCF / sales %i | -- | -- | 12.58 | -- | -- | 5.12 | -- | 3.10 |
| Current ratioi | 2.00 | 1.86 | 1.17 | 2.17 | 1.92 | 2.24 | 2.19 | 2.02 |
| Quick ratioi | 1.17 | 0.67 | 0.16 | 1.26 | 1.15 | 1.30 | 1.15 | 1.10 |
| Debt / assetsi | 58.86 | 19.96 | 21.74 | 48.08 | 44.28 | 40.53 | 35.29 | 33.35 |
| LT debt / equityi | 470.33 | 711.98 | -- | 183.91 | 171.49 | 124.53 | 80.43 | 75.42 |
| Interest coveragei | 0.49 | -0.97 | -0.33 | 0.10 | 1.71 | 2.42 | 2.28 | 2.53 |
| Revenue CAGR (3Y) %i | -20.86 | -3.13 | -19.46 | -11.50 | -0.48 | 18.36 | 15.56 | 4.48 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | 1.57 | -27.36 |
| FCF CAGR (3Y) %i | -- | -- | 55.37 | -- | -- | -12.30 | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 53.00 | 51.64 | 53.92 | 1.12 | 2.60 | 1.78 |
| ROA %i | 20.16 | 20.10 | 21.14 | 0.47 | 1.14 | 0.86 |
| ROIC %i | 30.16 | 29.72 | 31.04 | 3.42 | 3.36 | 2.66 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 8.88 | 9.67 | 9.47 | 6.95 | 7.75 | 6.91 |
| FCF / sales %i | -- | 1.79 | 1.00 | 3.10 | 0.43 | -- |
| Current ratioi | 2.54 | 2.47 | 2.35 | 2.02 | 2.02 | 2.46 |
| Quick ratioi | 1.42 | 1.42 | 1.38 | 1.10 | 1.03 | 1.61 |
| Debt / assetsi | 34.96 | 33.60 | 32.75 | 33.35 | 33.87 | 27.98 |
| LT debt / equityi | 75.23 | 70.89 | 68.76 | 75.42 | 71.99 | 49.98 |
| Interest coveragei | 2.53 | 3.05 | 3.15 | 2.53 | 3.08 | 2.97 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Completion Fluids & Products is the largest reported line at 60.92% of revenue, across 2 reported segments.
- Water & Flowback Services follows at 39.08%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Completion Fluids & Products60.92%
Water & Flowback Services39.08%
Quote time 2026-10-08 08:58:46 · For reference only, not investment advice and not tailored to your situation.